TECH Q2 Earnings & Revenues Beat Estimates, Operating Margin Up

Key Takeaways TECH posted Q2 adjusted EPS of 46 cents and revenues of $295.9M, beating consensus estimates. Bio-Techne saw Protein Sciences grow 2% while Diagnostics and Spatial Biology sales fell 4% year over year. TECH expanded operating margin 244 bps to 18.4% as operating profit rose to $54.5M. Bio-Techne Corporation (TECH) reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of 46 cents, which surpassed the Zacks Consensus Estimate by 8.2%. The bottom line was up 9.5% on a year-over-ye ...